How we collect and rank prices
Every price on this site is read from the seller's own page, dated and linked. Lists are ordered by price and nothing else.
Last revised 20 Nov 2026
- Sellers tracked
- 34
- Prices tracked
- 99
- Automatic checks
- Daily
- Last check
- 21 Nov 2026
What counts as a price
A price is what a new patient paying cash would be charged for one fill, as the seller states it on a public page, with no promo code. One fill is a 4-week supply unless the row says otherwise. Prices that depend on insurance, such as Lilly's savings card or the Medicare GLP-1 Bridge, sit in their own lists and are never mixed with cash prices.
How we collect prices
We read each price from the seller's own page. We do not take prices from other comparison sites, from press coverage or from readers. Every price is shown with the date we last read it and a link to the page it came from.
- Where a page can be read by machine, a script checks it every day.
- Where a page blocks scripts or builds its price in the browser, a person reads it by hand.
- A reading that moves more than 60% from the previous one is held. A person checks the page before the new figure is published.
- When a reading differs from the last one, we add a dated line to the price history.
How the all-in price per 4 weeks is built
The all-in price is the medication plus any recurring membership the seller requires before it will prescribe or fill. Sellers that charge no membership show the medication price alone. Where a seller's price already includes clinician access, we do not add a fee twice.
An example from today's data: PlushCare lists Zepbound single-dose vials, filled by LillyDirect at $299 for the 2.5 mg dose and charges a membership of $19.99 a month. The all-in price is $318.99 per 4 weeks.
The all-in price leaves out costs we cannot read from a seller's page. Those include your own clinician's visit charge and the needles and syringes that Lilly sells separately for vials (LillyDirect, checked 20 Nov 2026).
Why 4 weeks and not a month
Lilly defines a month of Zepbound as 28 days: four weekly doses, supplied as four single-dose vials or pens, or one KwikPen (savings card terms and LillyDirect, checked 20 Nov 2026). Thirteen 28-day fills make 364 days, so a year of treatment takes 13 fills. A seller that bills by the calendar month is shown with the supply it states.
How the 12-month total is computed
The 12-month total is the first fill at the first-month price, plus twelve more fills at the ongoing all-in price. The first-month price uses any introductory medication price and the first-month membership the seller publishes.
For PlushCare at 2.5 mg, the first fill is $428 and each later fill is $318.99, which gives $4,255.88 over 12 months.
The total holds one dose for the whole year. The calculator steps through doses instead. From 7.5 mg up, the total uses Lilly's price for refills made within 45 days. The higher price for a late refill is shown in the row's conditions.
How ranking works
Lists are ordered by the all-in price per 4 weeks at the dose you select, lowest first. When two rows cost the same, the seller that adds no membership comes first, then the order is alphabetical. Rows with no published price for that dose go to the bottom in alphabetical order.
Commission never moves a row. A seller cannot pay to be listed, to be listed higher or to have a competitor removed. Sellers that pay us nothing are listed on the same terms as the rest. See how we make money.
What “from” and “Not published by seller” mean
A “from” price is a starting figure that the seller does not tie to a dose. We show it against the 2.5 mg starting dose only and mark it “from”. If the seller states one flat price for every dose, we apply it to every dose and drop the “from”.
“Not published by seller” means the seller's public page gives no price for that dose. We do not estimate the figure, and we do not start a sign-up to find it.
How compounded and FDA-approved products are kept apart
Zepbound and Mounjaro are FDA-approved. Compounded tirzepatide is not. Every compounded row carries a “Compounded · Not FDA-approved” tag, the two groups are never averaged together, and the lowest FDA-approved price on each page is worked out from FDA-approved rows only.
We do not list retatrutide or other substances that the FDA says cannot be used in compounding (FDA, page current as of 1 October 2026).
Confidence levels
Each price has a confidence level that says how clearly the seller's page states it.
- High. The page states the price plainly for a named product and supply. 24 of 41 offers today.
- Medium. The page gives only a starting price or a first-month price, or shows a figure we could not fully reconcile with the manufacturer's. 13 offers today.
- Low. The page shows conflicting figures, or a sale price with no regular price beside it. 4 offers today.
What we leave out
- Promo codes, coupon codes and prices that appear only after an intake form.
- Insurance copays, which depend on the plan. The exceptions are the published savings-card and Medicare figures.
- Sellers whose pages we could not read at all. On 20 Nov 2026 that included GoodRx, Eden and CVS.
- Prices reported by readers, and prices quoted by other comparison sites.
- Sellers outside the United States, and anything sold without a prescription.
- Review scores and ratings. We do not score sellers.
How we use automation
Scripts read the pages they can and compare each reading with the last. We also use software, including AI models, to help draft and check the text on this site. The publisher is responsible for everything that appears here, and a person checks any reading that the 60% rule holds back.
Medical review
There is none, because the site publishes no medical guidance. Statements about what a drug is approved for use the wording of the FDA label and link to it. See the editorial policy.
Corrections and data
If a price is wrong, tell us through the corrections page. Corrections are logged there with their dates. The full price table can be downloaded from the data page, and every source page we read is listed under sources.